Finance Watch: October Begins With A VC Mega-Round For Newly Named Iambic
Early Capital Sources Emerge From 65LAB, Novo/Evotec, Age1
Private Company Edition: Iambic, formerly known as Entos, closed a $100m series B venture capital round to advance its AI-discovered therapeutics. Also, Evozyne raised $81m and Acesion brought in €45m in series B rounds, while Mogrify added $10m to bring its series A to $46m.
